• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 12 of 30
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
TechGoogle DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By Jeremy KahnMay 8, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
RetailDenmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
Novo Nordisk CEO Lars Fruergaard Jorgensen Interview
RetailNovo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By Sanne Wass, Naomi Kresge and BloombergMay 1, 2024
Marijuana
PoliticsBiden’s DEA to reclassify marijuana in historic shift that still doesn’t decriminalize it, sources say
By Zeke Miller, Joshua Goodman, Jim Mustian, Lindsay Whitehurst and The Associated PressApril 30, 2024
Gavin Newsom
PoliticsFrustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses
By Adam Beam and The Associated PressApril 29, 2024
A scientist in a lab coat peers into a microscope in a lab.
NewslettersAI for drug discovery draws a $1 billion launch—and a lot of hope
By Sage LazzaroApril 25, 2024
Pascal Soriot, CEO of AstraZeneca. Under Soriot, Astra has invested heavily in cancer drugs.
RetailAstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By Ashleigh Furlong and BloombergApril 25, 2024
Felipe de Jesus Gallo
FinanceMexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia
By The Associated PressApril 23, 2024
Researchers at SUNY Upstate Medical University found that nonmedical cannabis use—regardless of how or how often it was consumed—lowered a person’s odds of subjective cognitive decline by 96%.
MindRecreational cannabis use may lower your risk of cognitive decline, study says
By Lindsey LeakeApril 19, 2024
The Waldos
Lifestyle‘It’s a phenomenon’: How 4/20 grew organically from a group of Northern California high schoolers into marijuana’s holiday
By Gene Johnson and The Associated PressApril 19, 2024
A pharmacist assists a customer with medical marijuana.
NewslettersMillions of Americans have used medical marijuana. Is it covered by their FSAs?
By Emma BurleighApril 19, 2024
Senior man holding several prescription medications
HealthHow Medicare beneficiaries with Part D plans can help ensure their medications are covered
By Richard EisenbergApril 8, 2024
ALS drug will be pulled from US market after study showed patients didn’t benefit
HealthALS drug will be pulled from US market after study showed patients didn’t benefit
By Matthew Perrone and The Associated PressApril 4, 2024
Tina Kotek
PoliticsOregon just officially changed its mind on decriminalizing drugs
By The Associated PressApril 1, 2024
Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed 
HealthDemand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed 
By Ike Swetlitz, Madison Muller and BloombergMarch 30, 2024
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...30
Most Popular
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AIplaceholder alt text
By Jake AngeloMay 16, 2026
Politics
Former top Russian official admits the country is over Putin and can 'imagine a future without him' — even elites bail as Kremlin seizes their assets placeholder alt text
By Jason MaMay 16, 2026
Future of Work
Meet the 20-year-old CEO who launched a company in high school to solve Gen Z's entry-level job crisisplaceholder alt text
By Jake AngeloMay 16, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.